Status of oropharyngeal and colonic microbiota, and phagocytic activity of peripheral blood neutrophiles in children with Mycoplasma pneumoniae infection


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

Infection caused by Mycoplasma pneumoniae is a significant public health problem due to the high prevalence, increasing incidence, a significant etiological role in the development of community-acquired pneumonia. The article presents the results of the evaluation of the status of the oropharyngeal and colonic microbiota and the phagocytic activity of peripheral blood neutrophils in 91 children aged 1 to 7 years who were admitted to a hospital with acute upper and lower respiratory tract infections. Mycoplasma infection (MI) was diagnosed in 35.3% of the examined children, incl. community-acquired pneumonia - in 8,8%. Patients with MI were diagnosed with a severe dysbiosis on the mucous membranes of the oropharynx and intestine, whose markers were a deficiency in growth of Neisseria and Escherichia, respectively, and high isolation rates of Gram-negative enterobacteria, Pseudomonas aeruginosa and Candida fungi (50% and 100%, respectively). In patients with MI (in comparison with acute respiratory diseases of other etiology), deeper violations of the lysing function of peripheral blood phagocytic neutrophils and incomplete phagocytosis, more pronounced in pneumonia, were revealed.

Толық мәтін

Рұқсат жабық

Авторлар туралы

E. Meskina

SBHCI MR Moscow Regional Scientific Research Clinical Institute n.a. M.F. Vladimirsky

M. Khadisova

SBHCI MR Moscow Regional Scientific Research Clinical Institute n.a. M.F. Vladimirsky

Email: murzabekova.marina.1979@mail.ru
PhD, Researcher at the Department of Children’s Infectious Diseases

E. Rusanova

SBHCI MR Moscow Regional Scientific Research Clinical Institute n.a. M.F. Vladimirsky

Әдебиет тізімі

  1. Самсыгина Г.А. Микоплазмоз респираторного тракта у детей и подростков. Consillium Medicum. Приложение. Педиатрия. 2011; 4: 67-70.
  2. Marchello C., Dale A.P., Thai T.N., Han D.S., Ebell M.H. Prevalence of Atypical Pathogens in Patients With Cough and Community-Acquired Pneumonia: A Meta-Analysis. Ann. Fam. Med. 2016; 14(6): 552-66.
  3. Yamazaki T., Kenri T. Epidemiology of Mycoplasma pneumoniae Infections in Japan and Therapeutic Strategies for Macrolide-Resistant M. pneumoniae. Front. Microbiol. 2016; 7: 693.
  4. Sun H., Xue G., Yan C., Li S., Zhao H., Feng Y., Wang L. Changes in Molecular Characteristics of Mycoplasma pneumoniae in Clinical Specimens from Children in Beijing between 2003 and 2015. PLoS One. 2017; 12(1): e0170253.
  5. Tian D.D., Jiang R., Chen X.J., Ye Q. Meteorological factors on the incidence of MP and RSV pneumonia in children. PLoS One. 2017; 12(3): e0173409. doi: 10.1371/journal.pone.0173409. eCollection 2017.
  6. Liao J.Y., Zhang T. Distribution characteristics of Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila in hospitalized children with acute respiratory tract infection: an analysis of 13 198 cases. Zhongguo Dang Dai Er Ke Za Zhi. 2016; 18(7): 607-13.
  7. Jain S., Williams D.J., Arnold S.R., Ampofo K., Bramley A.M., Reed C., Stockmann C., Anderson E.J., Grijalva C.G., Self W.H., Zhu Y., Patel A., Hymas W., Chappell J.D., Kaufman R.A., Kan J.H., Dansie D., Lenny N., Hillyard D.R., Haynes L.M., Levine M., Lindstrom S., Winchell J.M., Katz J.M., Erdman D., Schneider E., Hicks L.A., Wunderink R.G., Edwards K.M., Pavia A.T., McCullers J.A., Finelli L; CDC EPIC Study Team. Community-acquired pneumonia requiring hospitalization among U.S. children. N. Engl. J. Med. 2015; 372(9): 835-45.
  8. Narita M. Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia. J. Infect. Chemother. 2010; 16: 162-69.
  9. Izumikawa K. Clinical Features of Severe or Fatal Mycoplasma pneumoniae Pneumonia. Front Microbiol. 2016; 7: 800.
  10. Spuesens E.B., Fraaij PL., Visser E.G., Hoogenboezem T., Hop W.C., van Adrichem L.N., Weber F., Moll H.A., Broekman B., Berger M.Y., van Rijsoort-Vos T., van Belkum A., Schutten M., Pas S.D., Osterhaus A.D., Hartwig N.G., Vink C., van Rossum A.M. Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study. PLoS Med. 2013; 10(5): e1001444.
  11. Nilsson A.C., Bjorkman P, Persson K. Polymerase chain reaction is superior to serology for the diagnosis of acute Mycoplasma pneumoniae infection and reveals a high rate of persistent infection. BMC. Microbiol. 2008; 8: 93.
  12. Saraya T., Nakata K., Nakagaki K., MotoiN., Iihara K., Fujioka Y., Oka T., Kurai D., Wada H., Ishii H., Taguchi H., Kamiya S., Goto H. Identification of a mechanism for lung inflammation caused by Mycoplasma pneumoniae using a novel mouse model. Results Immunol. 2011; 1(1): 76-87.
  13. Chaudhry R., Ghosh A., Chandolia A. Pathogenesis of Mycoplasma pneumoniae: An update. Indian. J. Med. Microbiol. 2016; 34(1): 7-16.
  14. Techasaensiri C, Tagliabue C.,Cagle M.,Iranpour P, Katz K., Kannan T.R., Coalson J.J., Baseman J.B., Hardy R.D. Variation in colonization, ADP-ribosylating and vacuolating cytotoxin, and pulmonary disease severity among mycoplasma pneumoniae strains. Am. J. Respir. Crit. Care Med. 2010; 182(6): 797-804.
  15. Jiang W., Yan Y., Ji W., Wang Y., Chen Z. Clinical significance of different bacterial load of Mycoplasma pneumoniae in patients with Mycoplasma pneumoniae pneumonia. Braz. J. Infect. Dis. 2014; 18: 124-28.
  16. de Steenhuijsen Piters W.A., Sanders E.A., Bogaert D. The role of the local microbial ecosystem in respiratory health and disease. Philos. Trans R Soc. bond B Biol. Sci. 2015; 19; 370(1675).
  17. Marsland B.J., Trompette A., Gollwitzer E.S. The Gut-Lung Axis in Respiratory Disease Ann. Am. Thorac. Soc. 201512(Suppl. 2): 150-56.
  18. Wang H., Dai W., Qiu C., Li S., Wang W., Xu J., Li Z., Wang H., Li Y., Yang Z., Feng X., Zhou Q., Han L., Li Y., Zheng Y. Mycoplasma pneumoniae and Streptococcus pneumoniae caused different microbial structure and correlation network in lung microbiota. J. Thorac. Dis. 2016; 8(6): 1316-22.
  19. Rosas-Salazar C., Shilts M.H., Tovchigrechko A., Schobel S., Chappell J.D., Larkin E.K., Shankar J., Yooseph S., Nelson K.E., Halpin R.A., Moore M.L., Anderson L.J., Peebles R.S., Das S.R., Hartert T.V. Differences in the Nasopharyngeal Microbiome During Acute Respiratory Tract Infection With Human Rhinovirus and Respiratory Syncytial Virus in Infancy. J. Infect. Dis. 2016; 214(12): 1924-28.
  20. Внебольничная пневмония у детей. Клинические рекомендации. Российское респираторное общество. Межрегиональное педиатрическое респираторное общество. Федерация педиатров стран СНГ. Московское общество детских врачей. М., 2015. 64 с.
  21. Эпштейн-Литвак Р.В. Бактериологическая диагностика дисбактериоза. Методические рекомендации. М., 1977: 20.
  22. Воропаева Е.А. Микробная экология и гистаминобразующая активность микроорганизмов задней стенки глотки детей, больных бронхиальной астмой. Дисс.. канд. мед. наук. М., 2002.
  23. Лебедев К.А., Понякина И.Д. Иммунограмма в клинической практике. М., 1990. 223 с.
  24. Феклисова Л.В., Мескина Е.Р., Галкина Л.А., Целипанова Е.Е., Савицкая Н.А., Воропаева Е.А. Современные подходы к коррекции микробиоценоза ротоглотки. Леч. врач. 2009; 10: 1-3.
  25. Biesbroek G., Tsivtsivadze E., Sanders E.A., Montijn R., Veenhoven R.H., Keijser B.J., Bogaert D. Early respiratory microbiota composition determines bacterial succession patterns and respiratory health in children. Am. J. Respir. Crit. Care Med. 2014; 190: 1283-12.
  26. Pettigrew M.M., Gent J.F., Kong Y., Wade M., Gansebom S., Bramley A.M., Jain S., Arnold S.L., McCullers J.A. Association of sputum microbiota profiles with severity of community-acquired pneumonia in children. BMC. Infect. Dis. 2016; 16: 317.
  27. Lee W.J., Huang E.Y., Tsai C.M., Kuo K.C., Huang Y.C., Hsieh K.S., Niu C.K., Yu H.R. Role of Serum Mycoplasma pneumoniae IgA, IgM, and IgG in the Diagnosis of Mycoplasma pneumoniae-Related Pneumonia in School-Age Children and Adolescents. Clin. Vaccine Immunol. 2017; 24(1): e00471-16.
  28. Королева Е.Г., Осидак Л.В., Милькинт К.К., Головачева Е.Г., Румель Н.Б., Орлов А.В., Потапенко Л.Б. Респираторная микоплазменная инфекция у детей с отягощенным преморбидным фоном. Дет. инфекции. 2004: 4: 17-22.
  29. Широбоков В.П. Медицинская микробиология, вирусология и иммунология. Винница, 2015. 898 с.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

© Bionika Media, 2018

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>